Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Genzyme receives positive opinion for Renvela in patients with kidney disease

March 23, 2009

Propiverine shows good combination of efficacy and tolerability in neurogenic detrusor overactivity

March 18, 2009

Phase III Rituxan study did not meet primary endpoint in lupus nephritis

March 13, 2009

Taiho and Toray initiate codevelopment of beta3-adrenoceptor agonist TRK-380/TAC-301

March 12, 2009

Fosrenol launched in Japan for hyperphosphatemia

March 12, 2009

AEterna Zentaris and sanofi-aventis sign agreement for cetrorelix in U.S. market

March 10, 2009

Darifenacin reduces incontinence in overactive bladder patients

March 5, 2009

Anticonvulsants improve urodynamic parameters in rats with NDO

March 4, 2009

Serlopitant effective but less so than tolterodine in overactive bladder

March 3, 2009

Serenity completes phase II clinical trial of CPEX Pharmaceuticals' urology drug

March 2, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...